LEADER 05740nam 2200625Ia 450 001 9910438131603321 005 20200520144314.0 010 $a1-60761-548-7 024 7 $a10.1007/978-1-60761-548-4 035 $a(CKB)2670000000245984 035 $a(EBL)1156170 035 $a(OCoLC)831115887 035 $a(SSID)ssj0000737222 035 $a(PQKBManifestationID)11439991 035 $a(PQKBTitleCode)TC0000737222 035 $a(PQKBWorkID)10784114 035 $a(PQKB)10964793 035 $a(DE-He213)978-1-60761-548-4 035 $a(MiAaPQ)EBC1156170 035 $a(PPN)168305321 035 $a(EXLCZ)992670000000245984 100 $a19901101d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEndocrine hypertension $eunderlying mechanisms and therapy /$fChristian A. Koch, George P. Chrousos, editors 205 $a1st ed. 2013. 210 $aNew York $cHumana Press$d2012 215 $a1 online resource (322 p.) 225 0 $aContemporary endocrinology 300 $aDescription based upon print version of record. 311 $a1-62703-946-5 311 $a1-60761-547-9 327 $a Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics.-Syndromes of Mineralocorticoid Excess -- Hypertension in Patients with Cushing?s Syndrome -- Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos syndrome) and Hypersensitivity -- Congenital Adrenal Hyperplasia -- Adrenal Incidentalomas and Adrenal Hypertension -- Pheochromocytoma: Unmasking the Chameleon -- Hypertension in Growth hormone excess and deficiency -- Primary Hyperparathyroidism and Hypertension -- Hypertension, Vitamin D deficiency, and Calcium Metabolism -- Testosterone Deficiency or Male Hypogonadism -- Insulin Resistance and Hypertension -- Obesity-associated Hypertension.-Central mineralocorticoid receptors and cardiovascular disease.        Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics.-Syndromes of Mineralocorticoid Excess -- Hypertension in Patients with Cushing?s Syndrome -- Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos syndrome) and Hypersensitivity -- Congenital Adrenal Hyperplasia -- Adrenal Incidentalomas and Adrenal Hypertension -- Pheochromocytoma: Unmasking the Chameleon -- Hypertension in Growth hormone excess and deficiency -- Primary Hyperparathyroidism and Hypertension -- Hypertension, Vitamin D deficiency, and Calcium Metabolism -- Testosterone Deficiency or Male Hypogonadism -- Insulin Resistance and Hypertension -- Obesity-associated Hypertension.-Central mineralocorticoid receptors and cardiovascular disease.        Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics.-Syndromes of Mineralocorticoid Excess -- Hypertension in Patients with Cushing?s Syndrome -- Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos syndrome) and Hypersensitivity -- Congenital Adrenal Hyperplasia -- Adrenal Incidentalomas and Adrenal Hypertension -- Pheochromocytoma: Unmasking the Chameleon -- Hypertension in Growth hormone excess and deficiency -- Primary Hyperparathyroidism and Hypertension -- Hypertension, Vitamin D deficiency, and Calcium Metabolism -- Testosterone Deficiency or Male Hypogonadism -- Insulin Resistance and Hypertension -- Obesity-associated Hypertension.-Central mineralocorticoid receptors and cardiovascular disease.      . 330 $aThe prevalence of hypertension is almost three times as high as that of diabetes mellitus type 2, with both conditions being major risk factors for stroke, ischemic heart disease, cardiac arrhythmias, and heart failure.  The exact prevalence of hypertension related to hormonal derangements (endocrine hypertension) is not known but estimated to affect less than 15% of hypertensive patients.  Recent scientific discoveries have increased the understanding of the pathophysiologic mechanisms of hypertension.  In Endocrine Hypertension, a renowned panel of experts provides a comprehensive, state-of-the-art overview of this disorder, discussing when to assign an endocrine cause in one of  many conditions that may present with hypertension.   The first part of Endocrine Hypertension is dedicated to adrenal causes.  The second part of the volume concerns potential nonadrenal causes of hypertension, such as growth hormone excess or deficiency, primary hyperparathyroidism, vitamin D deficiency, testosterone deficiency, insulin resistance, obesity-associated hypertension, and the role of central mineralocorticoid receptors and cardiovascular disease. An important contribution to the literature, Endocrine Hypertension is an indispensable reference not only for endocrinologists, diabetologists, and adrenal investigators, but also for translational scientists and clinicians from cardiology, internal medicine, pediatrics, family medicine, geriatrics, urology, and reproductive medicine / gynecology. 410 0$aContemporary Endocrinology,$x2523-3785 606 $aHypertension$xEndocrine aspects 606 $aAdrenocortical hormones$xPhysiological effect 606 $aAdrenal glands$xDiseases$xComplications 615 0$aHypertension$xEndocrine aspects. 615 0$aAdrenocortical hormones$xPhysiological effect. 615 0$aAdrenal glands$xDiseases$xComplications. 676 $a616.1/32 676 $a616.132 701 $aKoch$b Christian A$01749887 701 $aChrousos$b George P$01749888 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910438131603321 996 $aEndocrine hypertension$94184350 997 $aUNINA